BioLineRx Ltd. Adjustments For Unrealised Foreign Exchange Losses Gains
BioLineRx Ltd. (BLRX) reported Adjustments For Unrealised Foreign Exchange Losses Gains of -$549.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains · last filed 2026-03-23
| Period end | Adjustments For Unrealised Foreign Exchange Losses Gains 6 month | Adjustments For Unrealised Foreign Exchange Losses Gains 12 month |
|---|---|---|
| 2025-12-31 | -$549.00K 20-F · filed 2026-03-23 | |
| 2025-06-30 | -$350.00K 6-K · filed 2025-08-14 | |
| 2024-12-31 | -$22.00K 20-F · filed 2026-03-23 | |
| 2024-06-30 | $221.00K 6-K · filed 2025-08-14 | |
| 2023-12-31 | $224.00K 20-F · filed 2026-03-23 | |
| 2023-06-30 | $344.00K 6-K · filed 2024-08-15 | |
| 2022-12-31 | $607.00K 20-F · filed 2025-03-31 | |
| 2022-06-30 | $562.00K 6-K · filed 2023-08-30 | |
| 2021-12-31 | -$207.00K 20-F · filed 2024-03-26 | |
| 2021-06-30 | $28.00K 6-K · filed 2022-08-16 | |
| 2020-12-31 | -$206.00K 20-F · filed 2023-03-22 | |
| 2020-06-30 | $21.00K 6-K · filed 2021-08-18 | |
| 2019-12-31 | -$108.00K 20-F · filed 2022-03-16 | |
| 2019-06-30 | -$34.00K 6-K · filed 2020-08-06 | |
| 2018-12-31 | $166.00K 20-F · filed 2021-02-23 | |
| 2018-06-30 | -$147.00K 6-K · filed 2019-08-06 | |
| 2017-12-31 | -$435.00K 20-F · filed 2020-03-12 | |
| 2017-06-30 | -$218.00K 6-K · filed 2018-08-13 | |
| 2016-12-31 | -$51.00K 20-F · filed 2019-03-28 | |
| 2015-12-31 | -$33.00K 20-F · filed 2018-03-06 |